A MYOTROPHIC AGENT AND GONADOTROPHIN INHIBITOR, 19-NORTESTOSTERONE-17-BENZOATE
- 1 June 1959
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 64 (6) , 1010-1016
- https://doi.org/10.1210/endo-64-6-1010
Abstract
19-Nortestosterone-17-benzoate, a new ester of 19-nortestosterone, has been compared with testosterone propionate for several biological activities. Testosterone propionate and 19-nortestosterone-17-benzoate are myotrophic and suppress production or release of pituitary gonadotrophins. Unlike testosterone propionate, the 19-nortestosterone derivative elicits these responses in doses which do not stimulate growth of seminal vesicles and ventral prostate in rats. The uterotrophic, anti-estrogenic and progestational potencies of the 2 androgens are similar. 19-Nortesto-sterone-17-benzoate is devoid of estrogenic activity. A 6-week study in intact and castrate male and female rats demonstrated that the biologic properties of 19-nortestosterone-17-benzoate are typical of those of an androgen. This steroid was orally inactive at the dose tested.Keywords
This publication has 5 references indexed in Scilit:
- THE MYOTROPHIC AND ANDROGENIC EFFECTS OF 17-ETHYL-19-NORTESTOSTERONE AND RELATED COMPOUNDSEndocrinology, 1956
- A COMPARISON OF MYOTROPHIC AND ANDROGENIC ACTIVITIES OF TESTOSTERONE PROPIONATE WITH 19-NORTESTOSTERONE AND ITS ESTERS1Endocrinology, 1954
- Myotrophic Activity of 19-Nortestosterone and Other Steroids Determined by Modified Levator Ani Muscle Method.Experimental Biology and Medicine, 1953
- THE INHIBITION OF GONADOTROPHIC HORMONE SECRETION BY PHYSIOLOGICAL DOSES OF ESTROGEN*Endocrinology, 1951
- The assay of progestinThe Journal of Physiology, 1934